The beginnings of regenerative medicine date back to basic research conducted in the 1960s and 1970s.
Research in this field began with the goal of regenerating tissues and organs damaged by disease or external factors and treating diseased or damaged areas.
And stem cell research played an important role in the early major advances in regenerative medicine.
In particular, the first bone marrow transplants were performed in the 1960s, which are considered the first successful examples of stem cell therapy,
This was followed by the first isolation of human embryonic stem cells (ES cells) in 1998, a discovery that marked a milestone in regenerative medicine.
ES cells are cells that have the ability to differentiate into any type of cell, indicating the theoretical possibility of regenerating any tissue in the body.
Furthermore, in 2006, Professor Shinya Yamanaka at Kyoto University discovered induced pluripotent stem cells (iPS cells). iPS cells can be created by reprogramming adult somatic cells back into a pluripotent state, providing an alternative means of generating stem cells without the ethical concerns associated with embryonic stem cells. This discovery significantly impacted the further development of regenerative medicine.
Today, regenerative medicine continues to evolve based on stem cell research and is now being explored as an alternative to organ transplantation and as a method to promote the regeneration of damaged tissues
At Ginza ALIVIO Clinic, our clinically experienced physicians provide a wide range of medical services tailored to each individual’s needs.
As full members of the Japanese Society for Regenerative Medicine, we are able to incorporate cutting-edge medical techniques on par with those used in university hospitals and large research institutions, enabling us to offer safe and effective regenerative and aesthetic regenerative therapies.
Our treatments include pain therapy and reverse aging using autologous adipose-derived mesenchymal stem cells, as well as skin regeneration therapies utilizing the patient’s own dermal fibroblasts.
We are officially authorized by the Ministry of Health, Labour and Welfare to perform these procedures, having obtained approval numbers for Class II and Class III regenerative medicine protocols from certified review boards.
Additionally, we offer treatments using stem cell-conditioned media, which contains a rich blend of exosomes (extracellular vesicles), cytokines, and amino acid residues produced during the culture of stem cells. These treatments are used for pain management, hair growth stimulation, skin regeneration, and erectile dysfunction (ED) therapy.
